Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
77 hedge funds and large institutions have $39.8M invested in Chembio diagnostics, Inc. in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 6 closing their positions.
317% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 6
31% more funds holding
Funds holding: 59 → 77 (+18)
30% more capital invested
Capital invested by funds: $30.5M → $39.8M (+$9.29M)
29% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 17
44% less call options, than puts
Call options by funds: $1.39M | Put options by funds: $2.49M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
Friess Associates
Greenville,
Delaware
|
+$2.87M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.13M |
| 3 |
Goldman Sachs
New York
|
+$1.03M |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$948K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$914K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.38M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$564K |
| 3 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
-$279K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$220K |
| 5 |
SC
Sculptor Capital
New York
|
-$167K |
CEMI Hedge Fund Activity: Q4 2020 in Review
77 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2020, worth a combined $39.8M — up 30% from $30.5M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new CEMI positions and 6 closed out — a net gain of 19 holders — while 22 added to existing stakes and 17 trimmed.
The largest buyer was Friess Associates, opening a new position worth an estimated $2.87M. The largest seller was Vanguard Group, cutting an estimated $1.38M.
- 77 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2020, up from 59 in Q3 2020.
- Funds reported $39.8M of Chembio diagnostics, Inc. stock for Q4 2020, up 30% quarter-over-quarter.
- 25 funds opened new Chembio diagnostics, Inc. positions in Q4 2020 and 6 closed out, a net change of +19 holders.
- The largest Chembio diagnostics, Inc. buyer in Q4 2020 was Friess Associates, an estimated $2.87M added.
- The largest Chembio diagnostics, Inc. seller in Q4 2020 was Vanguard Group, an estimated $1.38M sold.
Based on aggregated 13F filings for Q4 2020.